MedPath
HSA Approval

ALOSYN EYE DROPS

SIN13400P

ALOSYN EYE DROPS

ALOSYN EYE DROPS

January 24, 2008

PETER CHIA MARKETING PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPETER CHIA MARKETING PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SOLUTION, STERILE

OPHTHALMIC

Manufacturer Information

PETER CHIA MARKETING PTE. LTD.

ASHFORD LABORATORIES LTD.

Active Ingredients

TETRAHYDROZOLINE HYDROCHLORIDE

0.40MG/ML

Tetryzoline

ANTAZOLINE HYDROCHLORIDE

0.50MG/ML

Antazoline

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ALOSYN EYE DROPS - HSA Approval | MedPath